PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Medical Biology, Chinese Academy of Medicine Science and Peking Union Medical College, Yunnan Key Laboratory of Vaccine Research and Development for Severe Infectious Diseases, Kunming, China.\', \'Yunnan Center for Disease Control and Prevention, Kunming, China.\', \'Gejiu Center for Disease Control and Prevention, Gejiu, China.\', \'Mile Center for Disease Control and Prevention, Mile, China.\', \'National Institute of Food and Drug Control, Beijing, China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciaa1703
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 33165503
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Randomized, Double-Blinded, Placebo-Controlled Phase 2 Trial of an Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in Healthy Adults.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all